Key result
Phosphoproteomics maps vascular signaling networks to reveal novel cardiovascular biomarkers and therapeutic targets.
Design
Review
Answers are grounded in this paper and cite their sources.
This review highlights the utility of mass spectrometry-based phosphoproteomics in uncovering mechanistic insights and biomarker discovery in vascular biology and disease.
Phosphoregulatory events underlie vascular responses to environmental and pathological stimuli, regulate hemostasis and thrombosis, and drive vascular remodeling in health and disease. Consequently, defining phosphorylation-dependent signaling networks in vascular physiology and pathology has enabled biomarker discovery and informed therapeutic interventions. Advances in mass spectrometry-based phosphoproteomics have enabled accurate and high-resolution mapping of dynamic phosphorylation events at the systems level, providing comprehensive mechanistic insights into vascular signaling and pathology. In this review, we contextualize phosphorylation in the vascular niche and summarize the current state of phosphoproteomics in vascular research, highlighting experimental design considerations, technological advances, quantification strategies, and data analysis approaches to uncover biological insights from large-scale phosphoproteomic data sets. Finally, we discuss recent discoveries in vascular signaling and disease, along with current challenges and emerging directions for applying phosphoproteomics to critical questions in vascular biology.
No takes yet. Share an insight, caveat, or question.
Voos et al. (2026) reported a review. Mass spectrometry-based phosphoproteomics provides comprehensive mechanistic insights into vascular signaling and pathology, enabling biomarker discovery and informing therapeutic interventions.
Synapse has enriched 10 related papers. Consider them for comparative context: